DexCom
DXCM
$138.01
Share price
0.10%
Change (1 day)
11.33%
Change (1 year)
Categories
Operating Margin for DexCom (DXCM)
Operating Margin as of April 2024 (TTM): 13.43%
According to DexCom's latest financial reports and stock price the company's current Operating Margin is 13.43%. At the end of 2022 the company had an Operating Margin of 13.43%.
Operating Margin history for DexCom from 2006 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 13.43% | 89.1% |
| 2021 | 7.10% | -39.18% |
| 2020 | 11.68% | 65.42% |
| 2019 | 7.06% | -157.57% |
| 2018 | -12.26% | 81.29% |
| 2017 | -6.76% | -40.25% |
| 2016 | -11.32% | -20.86% |
| 2015 | -14.30% | 66.25% |
| 2014 | -8.60% | -53.81% |
| 2013 | -18.63% | -66.66% |
| 2012 | -55.86% | -5% |
| 2011 | -58.80% | -36.86% |
| 2010 | -93.13% | -39.67% |
| 2009 | -154.36% | -71.25% |
| 2008 | -536.97% | -46.77% |
| 2007 | -1,008.77% | -55.62% |
| 2006 | -2,273.03% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 70.36% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | 16.16% | 🇺🇸 USA |
 Medtronic MDT | 17.17% | 27.85% | 🇮🇪 Ireland |
 Becton Dickinson BDX | 9.46% | -29.56% | 🇺🇸 USA |
 Edwards Lifesciences EW | 31.50% | 134.55% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | -25.16% | -287.34% | 🇺🇸 USA |
 QuidelOrtho QDEL | 2.15% | -83.99% | 🇺🇸 USA |
 West Pharmaceutical WST | 21.20% | 57.86% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.